ClinicalTrials HQ

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Active, not recruiting · NCT07502495 · Registry updated 2026-08-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic TargetsNutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitusActive, not recruitingPhase 22026-08-28NCT07502495

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Biomea Fusion Inc.3

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ark Clinical ResearchLong BeachUnited States20
Ark Clinical ResearchFountain ValleyUnited States6
Catalina Research Institute, LLCMontclairUnited States17
Central Research Associates, LLC dba Flourish ResearchBirminghamUnited States3
David Kavtaradze MD, IncCordeleUnited States2
Diabetes and Endocrinology Associates of Stark CountyCantonUnited States2
Elligo Health Research, Inc.AustinUnited States3
Epic Clinical ResearchLewisvilleUnited States17
Excel Clinical ResearchLas VegasUnited States19
Hope Clinical ResearchCanoga ParkUnited States14
Manassas Clinical Research CenterManassasUnited States11
Panax Clinical ResearchMiami LakesUnited States10
Paradigm Clinical Research Centers, LLCSan DiegoUnited States6
Southwest General Healthcare CenterFort MyersUnited States9
Synergy Group Medical LLCMissouri CityUnited States1
Synergy Groups MedicalHoustonUnited States5
Zenos Clinical ResearchDallasUnited States27